European Union
Exelixis has announced that the European Commission has approved COTELLIC, a combination therapy for unresectable or metastatic melanoma with a BRAF V600 mutation. This approval joins Switzerland (August 2015) and the United States (November 2015) as the third regulatory approval for COTELLIC. The therapy, discovered by Exelixis and developed by
European Union
The International Air Transport Association (IATA) has urged the European Commission to ensure that the upcoming European Union (EU) Aviation Package strengthens the competitiveness and connectivity of the European economy, and benefits European consumers. Airline Director General Tony Tyler emphasized the crucial role of air connectivity in driving economic and
European Union
The community of Sosnowiec in southern Poland has won a prestigious European Energy Service Award for its Energy Performance Contracting (EPC) Project with Siemens Poland. The project achieved significant energy and carbon dioxide savings in 87 school buildings. The European Energy Service Award ceremony recognized outstanding European projects and institutions
European Union
The European Union has ruled that Luxembourg and the Netherlands provided illegal state aid to Starbucks and Fiat Chrysler, respectively, in their aggressive tax avoidance strategies. The European Commission ordered both companies to pay between $22 million to $34 million for their tax deals, which are considered modest sums compared
European Union
Sigma-Aldrich Corporation has completed the sale of its Sigma-Aldrich-branded solvents and inorganics business in the European Economic Area (EEA) to Honeywell, including global rights to its Fluka brand. This sale is part of the commitments Sigma-Aldrich made to the European Union to receive approval for its $17 billion acquisition by
European Union
The European Commission has approved isavuconazole for the treatment of adult patients with invasive aspergillosis and mucormycosis, two life-threatening fungal infections often occurring in patients with cancer and other immunocompromised individuals. This approval marks a significant milestone for Basilea Pharmaceutica, as it allows the company to launch isavuconazole in major
European Union
The Food and Agriculture Organization (FAO) of the United Nations launched the Food and Agriculture Policy Decision Analysis (FAPDA) initiative in 2008 to provide technical advice to its member countries on policy development and analysis. The program aims to strengthen the capacity of governments and national institutions to monitor and
European Union
European economy is set to boost from lower oil prices and a weaker euro, according to Valdis Dombrovskis, European Commission's vice president. In an interview at the International Monetary Fund's (IMF) annual meeting, Dombrovskis noted that the slowdown in emerging markets poses some risk to the
European Union
Ukraine and Russia have reached an agreement on new gas deliveries for the winter season, with Moscow agreeing to cut its prices through decreasing export duties. This move is expected to allow Ukraine to purchase two billion cubic meters of gas for storage in its underground reservoirs. The price Ukraine
European Union
The European Commission has urged member states to work together to accelerate reforms to vehicle emissions tests, following the revelation of Volkswagen's scheme to deceive environmental regulators. The EU executive arm reiterated its previous warning about the risk of fraud in emissions tests, which was highlighted in a
European Union
The European Medicines Agency's Committee for Medical Products for Human Use (CHMP) has given a positive opinion for the marketing authorization of cobimetinib, a selective MEK inhibitor discovered by Exelixis, in combination with vemurafenib for the treatment of BRAF V600 mutation-positive unresectable or metastatic melanoma. This recommendation is
European Union
Alexion Pharmaceuticals, Inc. has announced that the European Commission has approved Strensiq, a treatment for hypophosphatasia (HPP), a rare and life-threatening metabolic disorder. The approval, announced on September 14, 2015, marks a significant milestone in the treatment of patients with HPP, a disease that affects fewer than 20 patients per
